Feasibility of Identifying a Chinese Study Population and Eligible Pediatric Cancer Cases, and Linking the Two Groups to Assess the Role of Periconceptional Folic Acid Supplements in Risk of Pediatric Cancer.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02160795|
Recruitment Status : Withdrawn
First Posted : June 11, 2014
Last Update Posted : December 16, 2019
- Pregnant women are encouraged to take the vitamin folate. It helps prevent some birth defects. Children of mothers who take it also have less risk of some cancers. Between 1993 and 1995, some women in China took the vitamin daily before and during early pregnancy. Another group did not. This study will follow up on children born to both sets of women. (The children were born between 1994 and 1996.) Researchers will use these data to study the link between folate and cancer in infants and children.
- To see if folate may reduce childhood cancer if women take it every day before and during early pregnancy.
- Mothers who took part in a Chinese folic acid study between 1993 and 1995 and their offspring.
- Mothers of children in the study will sign a consent form. The form lets the researchers review the child s medical history. They may also review data about their cancer diagnosis. The children will also sign a form.
|Condition or disease|
|Pediatric Leukemia Pediatric Brain Neoplasms Other Pediatric Cancers|
|Study Type :||Observational|
|Actual Enrollment :||0 participants|
|Official Title:||Feasibility of Identifying the Chinese Community Intervention Program (CIP) Population and Eligible Incident Pediatric Cancer Cases, and Linking the Cases to the Population to Assess the Role of Periconceptional Folic Acid Supplements in Risk of Pediatric Cancer (Pilot #N3)|
|Study Start Date :||March 27, 2014|
|Actual Primary Completion Date :||February 23, 2018|
|Actual Study Completion Date :||October 9, 2018|
- Pediatric cancer [ Time Frame: 1994-2015 ]outcomes include pediatric leukemia, pediatric brain tumors and other pediatric cancers
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02160795
|Principal Investigator:||Martha Linet, M.D.||National Cancer Institute (NCI)|